These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20350514)

  • 1. What variables were associated with the inducibility of ventricular fibrillation during electrophysiologic stimulation test in patients without apparent organic heart disease?
    Sugi N; Shimizu A; Ueyama T; Yoshiga Y; Doi M; Ohmiya T; Ohno M; Yoshida M; Matsuzaki M
    J Cardiol; 2010 Jul; 56(1):35-43. PubMed ID: 20350514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome.
    Ikeda T; Abe A; Yusu S; Nakamura K; Ishiguro H; Mera H; Yotsukura M; Yoshino H
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):602-7. PubMed ID: 16836706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
    Tada T; Kusano KF; Nagase S; Banba K; Miura D; Nishii N; Watanabe A; Nakamura K; Morita H; Ohe T
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):56-61. PubMed ID: 17916151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome.
    Chinushi M; Komura S; Izumi D; Furushima H; Tanabe Y; Washizuka T; Aizawa Y
    Pacing Clin Electrophysiol; 2007 May; 30(5):662-71. PubMed ID: 17461877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular late potential in patients with apparently normal electrocardiogram; predictor of Brugada syndrome.
    Mizobuchi M; Enjoji Y; Nakamura S; Muranishi H; Utsunomiya M; Funatsu A; Kobayashi T
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):266-73. PubMed ID: 19954504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.
    Doi A; Takagi M; Maeda K; Tatsumi H; Shimeno K; Yoshiyama M
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):688-96. PubMed ID: 20050961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan.
    Takagi M; Yokoyama Y; Aonuma K; Aihara N; Hiraoka M;
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1244-51. PubMed ID: 17900255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular repolarization restitution properties in patients exhibiting type 1 Brugada electrocardiogram with and without inducible ventricular fibrillation.
    Hayashi M; Takatsuki S; Maison-Blanche P; Messali A; Haggui A; Milliez P; Leenhardt A; Extramiana F
    J Am Coll Cardiol; 2008 Mar; 51(12):1162-8. PubMed ID: 18355653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.
    Kakihara J; Takagi M; Hayashi Y; Tatsumi H; Doi A; Yoshiyama M
    Heart Vessels; 2017 Sep; 32(9):1151-1159. PubMed ID: 28364267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3.
    Kamakura S; Ohe T; Nakazawa K; Aizawa Y; Shimizu A; Horie M; Ogawa S; Okumura K; Tsuchihashi K; Sugi K; Makita N; Hagiwara N; Inoue H; Atarashi H; Aihara N; Shimizu W; Kurita T; Suyama K; Noda T; Satomi K; Okamura H; Tomoike H;
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):495-503. PubMed ID: 19843917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome.
    Miyamoto K; Yokokawa M; Tanaka K; Nagai T; Okamura H; Noda T; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S; Shimizu W
    Am J Cardiol; 2007 Jan; 99(1):53-7. PubMed ID: 17196462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Letsas KP; Weber R; Astheimer K; Kalusche D; Arentz T
    Europace; 2010 Feb; 12(2):271-4. PubMed ID: 19897501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia.
    Ueyama T; Shimizu A; Esato M; Yoshiga Y; Sawa A; Suzuki S; Sugi N; Matsuzaki M
    Europace; 2008 Jan; 10(1):86-90. PubMed ID: 18037690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry.
    Probst V; Veltmann C; Eckardt L; Meregalli PG; Gaita F; Tan HL; Babuty D; Sacher F; Giustetto C; Schulze-Bahr E; Borggrefe M; Haissaguerre M; Mabo P; Le Marec H; Wolpert C; Wilde AA
    Circulation; 2010 Feb; 121(5):635-43. PubMed ID: 20100972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brugada syndrome associated with ventricular fibrillation induced by administration of pilsicainide: a case report].
    Matsumoto K; Sumita S; Ishikawa T; Matsushita K; Kobayashi T; Ohkusu Y; Yamakawa Y; Nakagawa T; Nakazawa I; Mochida Y; Ebina T; Uchino K; Kimura K; Umemura S
    J Cardiol; 2003 Nov; 42(5):227-34. PubMed ID: 14658412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study.
    Aiba T; Shimizu W; Hidaka I; Uemura K; Noda T; Zheng C; Kamiya A; Inagaki M; Sugimachi M; Sunagawa K
    J Am Coll Cardiol; 2006 May; 47(10):2074-85. PubMed ID: 16697328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
    Nagase S; Kusano KF; Morita H; Nishii N; Banba K; Watanabe A; Hiramatsu S; Nakamura K; Sakuragi S; Ohe T
    J Am Coll Cardiol; 2008 Mar; 51(12):1154-61. PubMed ID: 18355652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurally mediated syncope as a cause of syncope in patients with Brugada electrocardiogram.
    Yokokawa M; Okamura H; Noda T; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S; Shimizu W
    J Cardiovasc Electrophysiol; 2010 Feb; 21(2):186-92. PubMed ID: 19793146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brugada syndrome].
    Nakazawa K
    Kyobu Geka; 2007 Dec; 60(13):1171-6. PubMed ID: 18078085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.